![]() |
市場調查報告書
商品編碼
1967700
尿袋市場 - 全球產業規模、佔有率、趨勢、機會、預測:按產品、用途、產能、最終用途、地區和競爭格局分類,2021-2031年Urinary Bag Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Usage, By Capacity, By End Use, By Region & Competition, 2021-2031F |
||||||
全球尿袋市場預計將從 2025 年的 25.5 億美元成長到 2031 年的 32.5 億美元,複合年成長率為 4.13%。
這些無菌醫療設備對於收集和儲存尿失禁患者或術後復健患者的尿液至關重要。市場成長的主要驅動力是全球人口快速老化以及需要有效引流管理的慢性泌尿系統系統疾病盛行率不斷上升。例如,根據美國泌尿系統協會 (AUA) 2024 年的數據,預計 65 歲及以上男性良性前列腺增生 (BPH) 的盛行率將達到 29% 至 35%。如此高的盛行率確保了對尿液收集解決方案的持續需求,而手術數量的增加也進一步推動了這一領域的發展,使其不受暫時性設計趨勢的影響。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 25.5億美元 |
| 市場規模:2031年 | 32.5億美元 |
| 複合年成長率:2026-2031年 | 4.13% |
| 成長最快的細分市場 | 腿袋 |
| 最大的市場 | 北美洲 |
然而,導尿管相關的高感染風險是市場發展的一大障礙。為了確保病人安全並降低醫院的法律責任,醫療機構正日益實施嚴格的通訊協定,以盡可能縮短導尿時間。這種減少侵入性引流方式使用的臨床趨勢限制了尿袋在長期病患管理的應用。因此,這些安全措施對市場的整體擴張構成了重大阻礙因素。
全球老年人口的快速成長是推動市場發展的主要因素,因為老化、膀胱控制能力下降和行動不便之間有密切關聯。隨著預期壽命的延長,需要長期尿失禁解決方案(例如尿袋)的人數也在增加。根據美國國家人口與社會安全研究所於2024年9月發布的《2024年世界人口資料表》,65歲以上人口將超過8億,約佔總人口的10%。這種人口結構的變化確保了對可靠的尿液收集裝置的需求將持續穩定成長,不受經濟波動的影響,並促使製造商增加面向老年人,因為老年人患慢性泌尿系統疾病的風險較高。
此外,人們對居家醫療服務的日益青睞,正將病患管理從醫療機構轉移到家庭環境,加速市場成長。這種轉變推動了對隱藏易用型尿袋的需求,這些尿袋有助於患者進行自我管理,並改善慢性疾病患者的生活品質。在2024年11月發布的《2023/24年度報告》中,科樂普公司報告稱,其失禁護理部門實現了8%的內部成長,凸顯了醫院外對慢性病護理產品的強勁需求。需要手術治療的疾病的高發生率也印證了這個趨勢。根據美國癌症協會估計,2024年美國將新增83,190例膀胱癌病例,術後引流系統在急診和居家醫療環境中均持續存在需求。
全球尿袋市場的主要限制因素是導尿管相關尿道感染(CAUTI)的高風險。這種臨床風險迫使醫療機構從根本上重新思考其照護策略,並優先考慮儘早拔除留置導尿管,以降低醫院的法律責任。由於尿袋是與導尿管留置時間直接相關的耗材,醫院嚴格的使用限制通訊協定直接減少了製造商的轉售機會。因此,醫療機構轉向其他非侵入性尿失禁管理技術,以避免醫院感染帶來的嚴重經濟和聲譽損失,這在一定程度上限制了尿袋市場的發展。
這些排斥性做法的影響體現在近期產業指標中,這些指標顯示安全通訊協定與醫療設備使用量減少之間存在相關性。 Leapfrog Group報告稱,2024年其監測的各中心導尿管相關尿道感染下降了36%。這一顯著的統計降幅表明,全行業為減少對侵入性尿路器械的依賴所做的努力取得了成功。雖然這一趨勢有助於提高患者安全,但也意味著導尿管使用天數的大幅減少,進而顯著抑制了尿袋產業的銷售成長。
全球尿袋市場正經歷一場變革,而推動變革的動力正是生物分解和環保材料的廣泛應用。製造商正穩步從傳統的聚氯乙烯(PVC) 和一次性塑膠轉向可再生生物基聚合物和可回收替代品,這些替代品在保持臨床無菌性的同時,降低了對環境的影響,符合減少醫療塑膠廢棄物的環境永續性目標。這項轉變的驅動力來自監管要求和醫療保健採購政策,這些政策優先考慮低碳供應鏈,迫使該產業創新生產流程。例如,科樂普公司於 2025 年 11 月發布的 2024/25 年度報告指出,該公司已將其生產廢棄物回收率提高到 83%,超過了 75% 的目標,凸顯了失禁護理領域向循環製造的快速轉型。
同時,一次性感染預防系統正加速普及,先進的抗菌技術也正直接應用於引流產品中。為了應對導尿管相關尿道感染(CAUTI),市場正從標準引流袋朝向複雜的封閉式系統解決方案發展,這些解決方案採用抗菌塗層和改進的閥門,以防止細菌遷移。透過策略合作實現感染預防技術的商業性成長,也印證了這一趨勢。 2025年2月,Bactiguard Holding AB在其2024年財務業績報告中指出,其與貝克頓·迪金森公司(BD)合作的許可收入成長了33.9%,達到1.247億瑞典克朗,凸顯了旨在提高患者安全性的塗層尿路裝置的廣泛應用。
The Global Urinary Bag Market is projected to expand from USD 2.55 Billion in 2025 to USD 3.25 Billion by 2031, registering a CAGR of 4.13%. These sterile medical devices are essential for collecting and storing urine for patients suffering from incontinence or recovering from surgery. The market is primarily propelled by a rapidly aging global population and an increasing prevalence of chronic urological conditions that require effective drainage management. For instance, data from the American Urological Association in 2024 indicates that the prevalence of benign prostatic hyperplasia in men aged 65 and older has reached between 29% and 35%. This high incidence rate guarantees sustained demand for urine collection solutions, while rising surgical volumes further strengthen the sector, irrespective of transient design trends.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.55 Billion |
| Market Size 2031 | USD 3.25 Billion |
| CAGR 2026-2031 | 4.13% |
| Fastest Growing Segment | Leg Bags |
| Largest Market | North America |
However, the market encounters significant hurdles due to the elevated risk of infections linked to urinary catheters. To ensure patient safety and mitigate hospital liabilities, healthcare facilities are increasingly adopting strict protocols designed to minimize the duration of catheterization. This clinical transition toward reducing the use of invasive drainage methods restricts the adoption of urinary bags for long-term patient management. Consequently, these safety measures act as a notable constraint on the overall expansion of market volume.
Market Driver
The rapid growth of the global geriatric population serves as a major driver for market adoption, given the strong correlation between aging, loss of bladder control, and mobility issues. As life expectancy rises, there is a proportional increase in the number of people requiring long-term incontinence solutions, such as urinary bags. According to the Population Reference Bureau's '2024 World Population Data Sheet' from September 2024, the global population aged 65 and over has exceeded 800 million, accounting for roughly 10% of the total population. This demographic evolution ensures a steady and growing patient base that needs reliable urine collection devices regardless of economic fluctuations, encouraging manufacturers to ramp up production for an older demographic susceptible to chronic urological issues.
Furthermore, the increasing preference for home-based healthcare services is accelerating market momentum by moving patient management from clinical facilities to domestic settings. This shift fuels the demand for discreet, easy-to-use urinary bags that support self-care and enhance the quality of life for chronic patients. In its 'Annual Report 2023/24' published in November 2024, Coloplast reported that its Continence Care division achieved an organic growth rate of 8%, highlighting the strong demand for chronic care products outside of hospitals. This trend is also supported by the prevalence of conditions needing surgical care; the American Cancer Society estimated 83,190 new urinary bladder cancer diagnoses in the United States in 2024, maintaining the need for post-operative drainage systems in both acute and home care environments.
Market Challenge
The expansion of the Global Urinary Bag Market is primarily hindered by the high risk of catheter-associated urinary tract infections (CAUTIs). This clinical danger has compelled healthcare providers to fundamentally revise their care strategies, prioritizing the early removal of indwelling catheters to reduce hospital liabilities. Since urinary bags are consumable items directly linked to the length of catheterization, rigorous hospital protocols that curtail usage duration directly decrease recurring sales for manufacturers. Consequently, the market faces restrictions as medical facilities switch patients to alternative, non-invasive incontinence management techniques to circumvent the serious financial and reputational repercussions associated with hospital-acquired conditions.
The effect of these exclusionary practices is reflected in recent industry metrics that establish a link between safety protocols and diminished device utilization. The Leapfrog Group reported a 36% decrease in catheter-associated urinary tract infections across monitored facilities in 2024. This substantial statistical decline indicates a successful industry-wide initiative to reduce dependence on invasive urinary devices. Although this trend benefits patient safety, it signifies a considerable reduction in total catheter days, thereby acting as a significant restraint on the volume growth of consumables within the urinary bag sector.
Market Trends
The Global Urinary Bag Market is being transformed by the adoption of biodegradable and eco-friendly materials, as manufacturers align with environmental sustainability targets to cut down on medical plastic waste. Major medical device companies are steadily shifting away from traditional polyvinyl chloride (PVC) and single-use plastics in favor of renewable, bio-based polymers and recyclable alternatives that preserve clinical sterility while lowering ecological impact. This transition is propelled by regulatory demands and healthcare procurement policies that favor low-carbon supply chains, forcing the industry to innovate its production processes. For example, Coloplast's 'Annual Report 2024/25' from November 2025 notes that the company increased its production waste recycling rate to 83%, exceeding its 75% goal and emphasizing the rapid shift toward circular manufacturing in the continence care sector.
At the same time, there is an accelerated move toward single-use disposable systems aimed at infection prevention, incorporating advanced antimicrobial technologies directly into drainage products. To fight catheter-associated urinary tract infections (CAUTIs), the market is advancing from standard drainage bags to complex, closed-system solutions equipped with anti-infective coatings and improved valves to stop bacterial migration. This trend is demonstrated by the commercial growth of infection-preventing technologies through strategic alliances. In February 2025, Bactiguard Holding AB reported in its 'Year-end report 2024' that license revenues from its partnership with Becton, Dickinson and Company (BD) rose by 33.9% to SEK 124.7 million, highlighting the increasing adoption of coated urinary devices meant to improve patient safety.
Report Scope
In this report, the Global Urinary Bag Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Urinary Bag Market.
Global Urinary Bag Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: